Cited by 102Liver Diseases and ImmunityIgG4-Related and Inflammatory DiseasesDrug-Induced Hepatotoxicity and Protection

Autoimmune hepatitis and its variant syndromes

Open access
BEN-ARI, Z, CZAJA, A J·2001·Gut

Abstract

Autoimmune hepatitis and its variant syndromes Autoimmune hepatitis (AIH) is characterised by female predominance, interface hepatitis, hypergammaglobulinaemia, and autoantibodies.1 2 Typically, the disease responds well to corticosteroid therapy, and clinical, laboratory, and histological remission can be achieved in 65% of patients within 18 months.3 4 Among Caucasoid Northern Europeans, its mean annual incidence is 1.9 per 100 000, and its point prevalence is 16.9 per 100 000. 5 In the USA, AIH aVects 100 000-200 000 individuals.6 It accounts for 2.6% of the liver transplants in the European Liver Transplant Registry 7 and 5.9% of liver transplants in the USA.8 Classical autoimmune hepatitis Three types of AIH have been proposed based on immunoserological findings but only two types have mutually exclusive autoantibodies and diVerent clinical profiles.9 Type 1 AIH is the most common form of the disease worldwide and is associated with antinuclear antibodies (ANA) and/or smooth muscle antibodies (SMA).It aVects all age groups and is associated with human leucocyte antigen (HLA) DR3 (DRB1*0301) and DR4 (DRB1*0401) in Caucasoid Northern European and North American patients.10 11 DRB1*0301 and DRB1*0401 influence disease expression and behaviour as well as susceptibility.Caucasoid patients with type 1 AIH and DRB1*0301 are younger, and have a higher frequency of treatment failure, 12 relapse after drug withdrawal, 13 and requirement for liver transplantation than patients with other alleles.14 In contrast, patients with DRB1*0401 are typically older, frequently have concurrent autoimmune diseases, and respond better to corticosteroids than counterparts with DRB1*0301.15 Type 2 AIH aVects mainly children and is characterised by antibodies to liver/kidney microsome type 1 (anti-LKM1).16 The target autoantigen of type 2 AIH is the cytochrome mono-oxygenase P450 IID6 (CYP2D6), 17 18 and five antigenic sites located between [257][258][259][260][261][262][263][264][265][266][267][268][269][373][374][375][376][377][378][379][380][381][382][383][384][385][386][387][388][389][410][411][412][413][414][415][416][417][418][419][420][421][422][423][424][425][426][427][428][429] The main antigenic site is the peptide sequence 257-269 and the second most recognised sequence is 321-351.Most patients with type 2 AIH have anti-LKM1 that react against one of these short linear sequences, 19 20 and this reactivity distinguishes them from those patients with anti-LKM1 and chronic hepatitis C. 21 22 Susceptibility to type 2 AIH appears to relate to DRB1*0701, 23 24 but HLA B14, DR3, and C4A-QO have also been incriminated.25 Immune diseases (especially vitiligo, autoimmune thyroiditis, and insulin dependent diabetes mellitus) and organ specific autoantibodies (antibodies to thyroid, parietal cell, and/or islets of Langerhans) occur commonly.16 Initial studies that suggested a poorer outcome in type 2 than in type 1 AIH 16 have not been substantiated, and both type 1 and type 2 disease respond comparably to corticosteroids.26 27 Both types can have an acute, even fulminant, presentation, and prompt recognition and treatment are necessary to control inflammatory activity.[28][29][30] AIH in association with anti-LKM1 has also been described in 15% of patients with autoimmune polyglandular syndrome type 1 (APS1).[31][32][33] This syndrome is caused by a single gene mutation located on chromosome 21q22.3.34 35 The APS1 gene encodes for a transcription

Integrity signals

Registry

Crossref · 10.1136/gut.49.4.589

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

3 of the 158 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
BEN-ARI, Z., & CZAJA, A. J.
Affiliations
Liver Transplant Unit, Rabin Medical Center
Venue
Gut
Publisher
BMJ
Published
2001-10-01
Volume
49
Issue
4
Pages
589-594
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W1982477121
Cited by
102
References
158
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 4
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords
autoimmune hepatitis, type 1 autoimmune hepatitis, type 2 autoimmune hepatitis, HLA-DRB1, HLA-DR3, HLA-DR4, anti-LKM-1 antibodies, CYP2D6
MeSH terms
Adult, Algorithms, Child, Female, HLA Antigens, Humans, Male, Syndrome, Hepatitis, Autoimmune

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review